Trials / Completed
CompletedNCT00162058
A Phase II Study of DMP 115 to Assess Focal Liver Lesions
An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (planned)
- Sponsor
- Lantheus Medical Imaging · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine the optimal dose of DMP 115 to image liver lesions and to assess whether contrast can improve the detection of focal liver lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Peflutren Lipid Microsphere Injectable Suspension |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2006-04-01
- Completion
- 2006-04-01
- First posted
- 2005-09-13
- Last updated
- 2011-08-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00162058. Inclusion in this directory is not an endorsement.